SCHEMBL1811999

SCHEMBL1811999

OB(O)Oc1ccc2ncccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
NPC1 O15118 4/20 0.52
RAB9A P51151 3/20 0.52
POLB P06746 2/20 0.52
MAPT P10636 3/20 0.49
HTT P42858 3/20 0.49
ATM Q13315 2/20 0.49
CASP1 P29466 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
TSHR P16473 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ALOX15 P16050 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP3A4 P08684 2/20 0.45
CASP3 P42574 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17164822 0.80 NPC1 (0.61) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL29642010 0.79 ALDH1A1 (0.52) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL27845405 0.78 HTT (0.41) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL30501661 0.77 CYP1A2 (0.47) ALDH1A1RAB9AMAPTKDM4ESMN1; SMN2
SCHEMBL29168494 0.77 CYP1A2 (0.47) ALDH1A1RAB9AMAPTKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL8055454 0.77 NPC1 (0.57) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL7048352 0.77 NPC1 (0.57) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL20981992 0.77 NPC1 (0.57) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL219324 0.77 PDGFRB (0.59) ALDH1A1NPC1RAB9APOLBMAPT
SCHEMBL18700380 0.76 ALDH1A1 (0.54) ALDH1A1NPC1RAB9APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321296-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 EP disclosed